• Contact Us
Pharmaceuticals & Life Sciences Blogs - VWV

Pharma & Life Sciences

Articles & Blogs Pharma & Life Sciences

UK Government Consults on Future Scheme for Intellectual Property Rights Exhaustion

Thursday, 08 July 2021

The UK Intellectual Property Office (UK IPO) has opened a consultation on the UK's future exhaustion regime for intellectual property rights (IPR).

UK Government Consults on Future Scheme for Intellectual Property Rights Exhaustion

Articles & Blogs Pharma & Life Sciences

MHRA Targets World-Leading Innovation and Safety in New Plan

Thursday, 08 July 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) has published its new three-year delivery plan, drawing on the recent successes in being the first regulator in the world to approve a COVID-19 vaccine.

MHRA Targets World-Leading Innovation and Safety in New Plan

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

UK Response to COVID-19 Pandemic Shows World-Leading Life Sciences Innovation

Thursday, 08 July 2021

To say it has been quite an 18 months is an understatement. The life sciences industry was hit hard in parts, with a pausing of clinical trials, investment in start-ups and prioritisation on COVID-19 treatments.

UK Response to COVID-19 Pandemic Shows World-Leading Life Sciences Innovation

Articles & Blogs Pharma & Life Sciences

How the UK Government Plans to Lead the World in Life Sciences

Monday, 07 June 2021

The UK has all the ingredients to be at the forefront of life sciences, with the links between world-leading academia, industry and care system. Never has this been more apparent than the starring role the UK took in the fight against COVID-19.

How the UK Government Plans to Lead the World in Life Sciences

Articles & Blogs Pharma & Life Sciences

NHS Pays for Babies to Receive Revolutionary £1.8m Gene Therapy Drug

Wednesday, 02 June 2021

Babies in the UK have started to receive Zolgensma, from Novartis Gene Therapies, on the NHS following a confidential deal. The drug, valued at £1.8m per treatment, is one of the most expensive medicines on the market.

NHS Pays for Babies to Receive Revolutionary £1.8m Gene Therapy Drug

Articles & Blogs Pharma & Life Sciences

European Commission Sues AstraZeneca Over Vaccines - Does It Have a Case?

Thursday, 27 May 2021

There was a very public spat earlier this year around the supply by AstraZeneca of vaccines to the European Commission. The Commission has complained about delays of the vaccine delivery and AZ's prioritisation of supplying other places such as the UK.

European Commission Sues AstraZeneca Over Vaccines - Does It Have a Case?

Articles & Blogs Pharma & Life Sciences

Innovation Gateway Project Gets Underway As ICR Calls for Collaborators

Tuesday, 18 May 2021

The Institute of Cancer Research (ICR) has once again shown its commitment to innovation as a pioneer in the oncology space as it launches a new incubator space for life science companies at The London Cancer Hub in Sutton, South London.

Innovation Gateway Project Gets Underway As ICR Calls for Collaborators

Articles & Blogs Pharma & Life Sciences

New UK-India Trade Deal - A Huge Win for Life Sciences

Thursday, 13 May 2021

Following Brexit, the UK is looking for new international trade opportunities. In life sciences, as well as other sectors, where better to push on than with India? That seems to be the UK Government's view.

New UK-India Trade Deal - A Huge Win for Life Sciences

Articles & Blogs Brexit Pharma & Life Sciences

New GB-NI Pharma Arrangements - VWV Client Provides Innovative Solution

Wednesday, 12 May 2021

After the last-minute deal between the United Kingdom and European Union in late 2020, what it all means in practice is still being discovered and worked through.

New GB-NI Pharma Arrangements - VWV Client Provides Innovative Solution

Articles & Blogs Pharma & Life Sciences

How Will New £18m 'Gene Therapy Innovation Hubs' Transform Care for Patients?

Thursday, 15 April 2021

LifeArc, the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council (BBSRC) have announced an £18m investment to create a new national network of cutting-edge 'Gene Therapy Innovation Hubs'.

How Will New £18m 'Gene Therapy Innovation Hubs' Transform Care for Patients?

Articles & Blogs Pharma & Life Sciences

UK Leading Exciting Future in Genomics and Precision Medicine

Thursday, 15 April 2021

The UK has a proud record in leading the world in genomics and precision medicine, and it has a bright future ahead in these exciting areas, which will be at the forefront of disease detection, prevention and cure for years to come.

UK Leading Exciting Future in Genomics and Precision Medicine

Articles & Blogs Pharma & Life Sciences

Is the UK Still an Attractive Location for Clinical Trials?

Thursday, 11 March 2021

There has been a 20% growth in the number of Advanced Therapy Medical Product ('ATMP') clinical trials in the UK since 2019. That is the headline coming out of The Cell and Gene Therapy Catapult's 2020 ATMP clinical trials database and report.

Is the UK Still an Attractive Location for Clinical Trials?

Articles & Blogs Pharma & Life Sciences

NHS to Lead World with Repurposed Medicines

Thursday, 11 March 2021

Blake Dark, Commercial Medicines Director of NHS England and NHS Improvement, has published a report entitled 'Opportunities to Repurpose Medicines in the NHS in England', to adopt off-patent, repurposed medicines into NHS clinical practice.

NHS to Lead World with Repurposed Medicines

Articles & Blogs Pharma & Life Sciences

How Collaborations Are Essential to the Future of Pharma

Thursday, 11 March 2021

From the UK's world-leading latest genomics projects to personalised targeted treatments and the use of AI technologies in pharma and drug discovery, there has never been a better time to discuss Britain's great life sciences future.

How Collaborations Are Essential to the Future of Pharma

Articles & Blogs Pharma & Life Sciences

How Can UK Health Data Be Used to Benefit Patients and Research?

Thursday, 11 March 2021

The Government has commissioned a review into the use of health data in the UK for research and analysis. The objective is the more efficient and safe use of the health data ultimately for the benefit of patients.

How Can UK Health Data Be Used to Benefit Patients and Research?